AI-generated summary
The authors randomized 30 stem cell transplant patients to low-level laser therapy or control to assess oral mucositis severity and inflammatory markers in saliva and blood. The laser group had less severe mucositis, and some markers changed, including MMP-2 in saliva and IL-10 in plasma, while most other markers did not differ. The authors note the mechanism does not appear to be fully explained by changes in these mediators.
- Participants
- 30
- Who or what was studied
- Patients undergoing hematopoietic stem cell transplantation receiving high-dose chemotherapy conditioning
- Limits stated in the abstract
- The authors describe the study as a randomized preliminary study with a small sample of 15 patients per group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Oral mucositis, Control group, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.